MA22927A1 - Procede pour la preparation de nouveaux composes. - Google Patents

Procede pour la preparation de nouveaux composes.

Info

Publication number: MA22927A1
Authority: MA; Morocco
Prior art keywords: preparation; new compounds; compounds; new
Prior art date: 1992-06-30

Application number

MA23217A

Other languages

English (en)

Inventor

Alan Holt Dennis

Alan Levy Mark

Original Assignee

Smithkline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-06-30

Filing date

1993-06-28

Publication date

1994-04-01

1993-06-28 Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp

1994-04-01 Publication of MA22927A1 publication Critical patent/MA22927A1/fr

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
- C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
- C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/0065—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified
- C07J7/007—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified not substituted in position 17 alfa
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
- C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Toxicology (AREA)
Steroid Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

MA23217A 1992-06-30 1993-06-28 Procede pour la preparation de nouveaux composes. MA22927A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB929213835A GB9213835D0 (en)	1992-06-30	1992-06-30	Compounds

Publications (1)

Publication Number	Publication Date
MA22927A1 true MA22927A1 (fr)	1994-04-01

Family

ID=10717920

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA23217A MA22927A1 (fr)	1992-06-30	1993-06-28	Procede pour la preparation de nouveaux composes.

Country Status (23)

Country	Link
EP (1)	EP0651643A4 (fr)
JP (1)	JPH08500821A (fr)
KR (1)	KR950702118A (fr)
CN (1)	CN1095382A (fr)
AP (1)	AP412A (fr)
AU (1)	AU4545993A (fr)
BG (1)	BG99313A (fr)
BR (1)	BR9306748A (fr)
CA (1)	CA2138956A1 (fr)
CZ (1)	CZ334694A3 (fr)
FI (1)	FI946189A0 (fr)
GB (1)	GB9213835D0 (fr)
HU (1)	HUT69409A (fr)
IL (1)	IL106158A0 (fr)
MA (1)	MA22927A1 (fr)
MX (1)	MX9303970A (fr)
NO (1)	NO945074L (fr)
OA (1)	OA10122A (fr)
RU (1)	RU94046378A (fr)
SI (1)	SI9300350A (fr)
SK (1)	SK159994A3 (fr)
WO (1)	WO1994000125A1 (fr)
ZA (1)	ZA934645B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5925774A (en)	1991-01-07	1999-07-20	Pherin Corporation	Estrenes for inducing hypothalamic effects
JPH07508032A (ja) *	1992-05-20	1995-09-07	メルク　エンド　カンパニー　インコーポレーテッド	５α−レダクターゼ阻害剤としての新規Δ−１７−及びΔ−２０オレフィン性並びに飽和１７β−置換４−アザ−５α−アンドロスタン−オン
US5543417A (en) *	1994-10-21	1996-08-06	Merck & Co., Inc.	Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents
GB201102913D0 (en)	2011-02-18	2011-04-06	Univ Birmingham	Novel therapeutic
JP2015129095A (ja)	2013-12-19	2015-07-16	ロレアル	組成物
CN114656514B (zh) *	2018-02-11	2024-05-14	江苏豪森药业集团有限公司	一种甾族类衍生物调节剂及其制备方法和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4954446A (en) *	1988-05-25	1990-09-04	Smithkline Beecham Corporation	Aromatic steroid 5-α-reductase inhibitors

1992
- 1992-06-30 GB GB929213835A patent/GB9213835D0/en active Pending
1993
- 1993-06-26 ZA ZA934645A patent/ZA934645B/xx unknown
- 1993-06-28 IL IL106158A patent/IL106158A0/xx unknown
- 1993-06-28 MA MA23217A patent/MA22927A1/fr unknown
- 1993-06-30 SI SI9300350A patent/SI9300350A/sl unknown
- 1993-06-30 WO PCT/US1993/006238 patent/WO1994000125A1/fr not_active Ceased
- 1993-06-30 AP APAP/P/1993/000542A patent/AP412A/en active
- 1993-06-30 EP EP93915499A patent/EP0651643A4/fr not_active Withdrawn
- 1993-06-30 MX MX9303970A patent/MX9303970A/es unknown
- 1993-06-30 BR BR9306748A patent/BR9306748A/pt not_active Application Discontinuation
- 1993-06-30 SK SK1599-94A patent/SK159994A3/sk unknown
- 1993-06-30 HU HU9403833A patent/HUT69409A/hu unknown
- 1993-06-30 RU RU94046378/04A patent/RU94046378A/ru unknown
- 1993-06-30 CN CN93109540A patent/CN1095382A/zh active Pending
- 1993-06-30 CZ CZ943346A patent/CZ334694A3/cs unknown
- 1993-06-30 CA CA002138956A patent/CA2138956A1/fr not_active Abandoned
- 1993-06-30 AU AU45459/93A patent/AU4545993A/en not_active Abandoned
- 1993-06-30 FI FI946189A patent/FI946189A0/fi not_active Application Discontinuation
- 1993-06-30 JP JP6502660A patent/JPH08500821A/ja active Pending
1994
- 1994-12-29 BG BG99313A patent/BG99313A/xx unknown
- 1994-12-29 NO NO945074A patent/NO945074L/no unknown
- 1994-12-29 KR KR1019940704802A patent/KR950702118A/ko not_active Withdrawn
- 1994-12-29 OA OA60599A patent/OA10122A/en unknown

Also Published As

Publication number	Publication date
IL106158A0 (en)	1993-10-20
AU4545993A (en)	1994-01-24
BG99313A (en)	1995-09-29
FI946189L (fi)	1994-12-30
NO945074L (no)	1995-02-16
SK159994A3 (en)	1996-01-10
EP0651643A1 (fr)	1995-05-10
ZA934645B (en)	1994-01-25
WO1994000125A1 (fr)	1994-01-06
CN1095382A (zh)	1994-11-23
JPH08500821A (ja)	1996-01-30
BR9306748A (pt)	1998-12-08
RU94046378A (ru)	1996-10-10
CA2138956A1 (fr)	1994-01-06
HUT69409A (en)	1995-09-28
SI9300350A (sl)	1993-12-31
MX9303970A (es)	1994-04-29
AP412A (en)	1995-09-29
KR950702118A (ko)	1995-06-19
GB9213835D0 (en)	1992-08-12
NO945074D0 (no)	1994-12-29
AP9300542A0 (en)	1993-07-31
EP0651643A4 (fr)	1995-10-04
FI946189A7 (fi)	1994-12-30
CZ334694A3 (en)	1995-10-18
FI946189A0 (fi)	1994-12-30
OA10122A (en)	1996-12-18

Publication	Publication Date	Title
MA22922A1 (fr)	1994-04-01	Procede pour la preparation de nouveaux composes .
MA23270A1 (fr)	1995-04-01	Procede pour la preparation de nouveaux composes.
MA22923A1 (fr)	1994-04-01	Procede de preparation de nouveaux composes .
MA23792A1 (fr)	1996-10-01	Procede pour la preparation de nouveaux composes
MA24011A1 (fr)	1997-07-01	Procede pour la preparation de nouveaux composes
MA23802A1 (fr)	1996-10-01	Procede pour la preparation de nouveaux composes
MA22970A1 (fr)	1994-04-01	Procede de praparation de nouveaux composes.
MA24426A1 (fr)	1998-07-01	Procede pour la preparation de nouveaux composes
FR2691326B1 (fr)	1994-08-05	Procede pour la production de composes antimicrobiens.
MA22955A1 (fr)	1994-04-01	Procede pour la preparation de nouveaux composes .
MA23254A1 (fr)	1995-04-01	Procede de preparation de nouveaux composes
MA23143A1 (fr)	1994-10-01	Procede pour la preparation de compositions vaccinantes .
MA22860A1 (fr)	1993-12-31	Procede pour la preparation de nouveaux composes.
MA23770A1 (fr)	1996-10-01	Procede pour la preparation de nouveaux composes
MA24427A1 (fr)	1998-07-01	Procede pour la preparation de nouveaux composes
MA21645A1 (fr)	1990-07-01	Procede pour la preparation de nouveaux derives d'rtemisinine.
MA23309A1 (fr)	1995-04-01	Procede de preparation de nouveaux composes.
MA23041A1 (fr)	1994-07-01	Procede de preparation de composes benzopyraniques substitues.
MA24355A1 (fr)	1998-07-01	Procede de preparation de nouveaux composes
MA21348A1 (fr)	1989-04-01	Procede pour la preparation de nouveaux derives aminoalcoxyphenyle.
MA23134A1 (fr)	1994-10-01	Procede pour la preparation d'aryl-piperidine carbinols .
MA23036A1 (fr)	1994-07-01	Procede pour la preparation de composes.
MA21984A1 (fr)	1991-07-01	Procede pour la preparation de derives de quilinone .
MA22927A1 (fr)	1994-04-01	Procede pour la preparation de nouveaux composes.
FR2733227B1 (fr)	1997-07-04	Procede pour la preparation de 1,1-difluoroethane